Disparity Emerges in Lilly Data on Schizophrenia Drug
Info Document Actions Print this Four a fifth day in a row, the New York Times gaave prominent coverage to the way Eli Lilly fraudulently marketed and covered up hazards about their psychiatric drug Zyprexa, based on leaked documents provided by Jim Gottstein, founder of PsychRights. Disparity Emerges in Lilly Data on Schizophrenia Drug Date…